GLEN R HANSON portrait
  • Senior Advisor, NIH, College Of Pharmacy
  • Director Utah Addiction Center, Office Of Sr Vp Health Sci
  • Professor, Sod - Education
  • Professor, Pharmacology And Toxicology

Research Keywords

  • Transmitter Release
  • Substance P
  • Stimulants of Abuse
  • Serotonergic Ligands
  • Receptors, Dopamine
  • Plasmalemmal and Vesicular Transporters
  • Norepinephrine
  • Neuropeptides
  • Neurochemistry
  • Monoamines
  • Microdialysis
  • Glutamates
  • Ganglia, Sensory
  • Free Radicals
  • Excitatory Amino Acids
  • Cholinergic Transmitter Systems
  • Cholinergic Ligands
  • Cardiac Electrophysiology
  • Antipsychotics


  • Report on Spice and its Regulation. Brown Bag meeting, Salt Lake City Government. November 19, 2010. Invited Talk/Keynote, Presented, 11/19/2010.
  • Reducing Prescription Drug Abuse. Juab Medical Coalition. Nephi, Utah. September 29, 2010. Invited Talk/Keynote, Presented, 09/29/2010.
  • Report on Spice, Salvia divinorum and Tramadol (Ultram). Utah Legislature Judiciary, Law Enforcement, and Criminal Justice Interim Committee. September 15, 2010. Invited Talk/Keynote, Presented, 09/15/2010.
  • Reducing Prescription Drug Misuse and Abuse. Sevier County Drug Abuse Conference, Richfield, Utah. September 11, 2010. Invited Talk/Keynote, Presented, 09/11/2010.
  • Report on Spice, Salvia divinorum and Tramadol (Ultram). Utah Legislature HHS Interim Committee. June 23, 2010. Salt Lake City, Utah. Invited Talk/Keynote, Presented, 06/23/2010.
  • Reducing Prescription Drug Misuse and Abuse. Two Bear River Health Department Seminars, Logan, Utah, April 29th and April 30th, 2010. Invited Talk/Keynote, Presented, 04/29/2010.
  • New Perspectives in Drug Addiction Diagnosis and Treatment. Behavioral Science & Health Senior Capstone lecture. University of Utah, March 30, 2010. Invited Talk/Keynote, Presented, 03/30/2010.
  • Drugs, Brains and Development. Keynote speaker. Utah State Office of Education Conference. St. George, UT. March 1, 2010. Invited Talk/Keynote, Presented, 03/01/2010.
  • The Science of Drug Abuse and Addiction. West Jordan High School, South Jordan Utah, February 11, 2010. Invited Talk/Keynote, Presented, 02/11/2010.


  • English, fluent.


  • Frankel, P.S., Hoonakker, A.J., Alburges, M.E., McDougall, J., Fleckenstein, A.E., and Hanson, G.R.: Response of Basal Ganglia Neurotensin System to Methamphetamine Self-Administration. J. Pharmacol. Exp. Therapeutics. 336 (2011) 1-7. Published, 01/2011.
  • Chu, P., Hadlock, G., Vieira-Brock, P., Stout, K., Hanson, G.R., and Fleckenstein, A.E.: Methamphetamine Alters Vesicular Monoamine Transporter-2 Function and Potassium-Stimulated Dopamine Release. J Neurochem. 115 (2010) 325-332. Published, 12/2010.
  • Hadlock, G., Chu, P., Walters, E., Hanson, G.R., and Fleckenstein, A.E.: Methamphetamine-Induced Dopamine Transporter Complex Formation and Dopaminergic Deficits: The Role of D2 Receptor Activation. J. Pharmacol. Exp. Ther. 335 (2010) 207-212. Published, 12/2010.
  • Hadlock, G.C., Baucum, A.J. 2nd, King, J.L., Horner, K.A., Cook, G.A., Gibb, J.W., Wilkins, D.G., Hanson, G.R., and Fleckenstein, A.E.: Mechanisms underlying methamphetamine-induced dopamine transporter complex formation. J. Pharmacol. Exp. Ther. 329 (2009) 169-74. Published, 10/2009.
  • Farnsworth, S.J., Volz, T.J., Hanson, G.R., and Fleckenstein, A.E..: Cocaine alters vesicular dopamine sequestration and Potassium-stimulated dopamine release: The role of D2 receptor activation. J. Pharmacol. Exp. Ther. 328 (2009) 1-6. Published, 07/2009.
  • Hanson, J.E., Birdsall, E., Seferian, K., Crosby, M., Keefe, Dristen, Gibb, J., Hanson, G.R., and Fleckenstein, A.E.: Methamphetamine-induced dopaminergic deficits and refractoriness to subsequent treatment. Eur. J. Pharmacol. 607 (2009) 68-73. Published, 07/2009.
  • Fleckenstein, A.E., Volz, T.J. and Hanson, G.R.: Psychostimulant-induced alterations in vesicular monoamine transporter-2 function: neurotoxic and therapeutic implications. Neuropharmacology 56 (2009) 133-138. Published, 06/2009.
  • Volz, T.J., Farnsworth, S.J, Hanson, G.R, and Fleckenstein, A.E.: Method development and validation of an in vitro model of the effects of methylphenidate on membrane-associated synaptic vesicles. J Neurosci Methods. 177 (2009) 177-182. Published, 04/2009.
  • Alburges, M.E., Frankel, P.S., Hoonakker, A.J., Hanson, G.R.: Responses of limbic and extrapyramidal substance P systems to nicotine treatment. Psychopharmacology (Berl) 201 (2009) 517-527. Published, 04/2009.
  • Volz, T.J., Farnsworth, S.J., Rowley, S.D., Hanson, G.R., and Fleckenstein: Age-dependent differences in dopamine transporter and vesicular monoamine transporter-2 function and their implications for methamphetamine neurotoxicity. Synapse 63 (2009) 147-51. Published, 03/2009.